↓ Skip to main content

XM02 is superior to placebo and equivalent to Neupogen™ in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel…

Overview of attention for article published in BMC Cancer, November 2008
Altmetric Badge

Citations

dimensions_citation
97 Dimensions

Readers on

mendeley
59 Mendeley